Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2022-10-02 History
Report ID 155808
Drug Identification Number 02439387
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION
Packaging size 10mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-04-01
Actual start date 2022-04-01
Estimated end date 2022-10-01
Actual end date 2022-09-27
Shortage status Resolved
Updated date 2022-10-02
Company comments Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be extending the backorder on our Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10 mL until October 1, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-10-02 English Compare
v11 2022-08-29 French Compare
v10 2022-08-29 English Compare
v9 2022-08-04 French Compare
v8 2022-08-04 English Compare
v7 2022-07-15 French Compare
v6 2022-07-15 English Compare
v5 2022-06-27 French Compare
v4 2022-06-27 English Compare
v3 2022-04-02 English Compare
v2 2022-03-01 French Compare
v1 2022-03-01 English Compare

Showing 1 to 12 of 12